Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Entospletinib effectively prevents eye and skin GVHD in mice.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Fluconazole is somewhat effective for skin-related sporotrichosis but less so for severe forms, and should be a backup treatment.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Individualized treatments may help manage Dercum's disease symptoms.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

High-dose vitamin D and an anti-inflammatory diet may help improve symptoms in autoimmune conditions like SLE and AA.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.